Salivary cortisol in women with major depressive disorder under selective serotonin reuptake inhibitors therapy

Archives of Women's Mental Health

Volumn 16, Issue 2, 2013, Pages 139-147

  Dziurkowska, Ewelina ^a   Wesolowski, Marek ^a   Dziurkowski, Maciej ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Hospital for Nervous and Mental Diseases   (Poland)

Author keywords

Cortisol; HPLC; Major depressive disorder; Saliva; Selective serotonin reuptake inhibitors

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUVOXAMINE; HYDROCORTISONE; PAROXETINE; SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE RELEASE; LENGTH OF STAY; MAJOR DEPRESSION; MONOTHERAPY; POLYPHARMACY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SALIVA LEVEL;

ADULT; AGED; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLUSTER ANALYSIS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYDROCORTISONE; MIDDLE AGED; POLAND; PRINCIPAL COMPONENT ANALYSIS; SALIVA; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 84879553969     PISSN: 14341816     EISSN: 14351102     Source Type: Journal    
DOI: 10.1007/s00737-013-0329-z     Document Type: Article

References (31)

1. Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M (2007) HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Res 155:245-256
2. Attenburrow M-J, Mitter PR, Whale R, Terao T, Cowen PJ (2001) Low-dose citalopram as a 5-HT neuroendocrine probe. Psychopharmacology 155:323-326
3. Baghai TC, Schule C, Zwanzger P, Minov C, Holme C, Padberg F, Bidlingmaier M, Strasburger CJ, Rupprecht R (2002) Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression. Psychoneuroendocrinology 27:385-399
4. Bhagwagar Z, Hafizi S, Cowen PJ (2002) Acute citalopram administration produces correlated increases in plasma and salivary cortisol. Psychopharmacology 163:118-120
5. Brummelte S, Galea LAM (2010) Depression during pregnancy and postpartum: contribution of stress and ovarian hormones. Prog Neuropsychopharmacol Biol Psychiatry 34:766-776
6. Chrousos GP (2011) Adrenocorticosteroids & adrenocortical antagonists. In: Katzung BG, Masters SB, Trevor AJ (eds) Basic and clinical pharmacology, 11th edn. McGraw-Hill, New York
7. Dziurkowska E, Wesolowski M (2009) Evaluation of two techniques for extraction of cortisol from human saliva. Chromatographia 70:769-774
8. Gröschl M, Rauh M (2006) Influence of commercial collection devices for saliva on the reliability of salivary steroids analysis. Steroids 71:1097-1100
9. Harmer CJ, Bhagwagar Z, Shelley N, Cowen PJ (2003) Contrasting effects of citalopram and reboxetine on waking salivary cortisol. Psychopharmacology 167:112-114
10. Hill T, Lewicki P (2006) Statistic, methods and applications: a comprehensive reference for science, industry, and data mining. StatSoft, Inc., Tulsa
11. Humble M (2000) Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy. Acta Psychiatr Scand 101:28-36
12. Lilliecreutz C, Theodorsson E, Sydsjö G, Josefsson A (2011) Salivary cortisol in pregnant women suffering from blood and injection phobia. Arch Womens Ment Health 14:405-411
13. Masharani U, Shiboski S, Eisner MD, Katz PP, Janson SL, Granger DA, Blanc PD (2005) Impact of exogenous glucocorticoids use on salivary cortisol measurement among adults with asthma and rhinitis. Psychoneuroendocrinology 30:744-752
14. Mondelli V, Gianotti L, Picu A, Daga GA, Giordano R, Berardelli R, Pariante CM, Fassino S, Ghigo E, Arvat E (2006) Neuroendocrine effects of citalopram infusion in anorexia nervosa. Psychoneuroendocrinology 31:1139-1148
15. Mück-Šeler D, Pivac N, Šagud M, Jakovljević M, Mihaljević-Peleš A (2002) The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Prog Neuropsychopharmacol Biol Psychiatry 26:1235-1243
16. Navinés R, Martin-Santos R, Gomez-Gil E, Martinez de Osaba MJ, Imaz ML, Gasto C (2007) Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response. Psychoneuroendocrinology 32:411-416
17. Nikisch G, Mathe AA, Czernik A, Thiele J, Bohner J, Eap CB, Agren H, Baumann P (2005) Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Psychopharmacology 181:751-760
18. Okugawa G, Omori K, Suzukawa J, Fujiseki Y, Kinoshita T, Inagaki C (1999) Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones. Neuroendocrinology 11:887-895
19. Otto M (1999) Chemometrics: statistics and computer application in analytical chemistry. Wiley, New York
20. Papadopoulos AS, Cleare AJ (2011) Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat Rev Endocrinol 8:22-32
21. Papadopoulos A, Ebrecht M, Roberts ADL, Poon L, Rohleder N, Cleare AJ (2009) Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test. J Affect Disord 112:289-294
22. Papakostas GI, Chuzi SE, Sousa JL, Fava M (2010) 5-HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response. Eur Arch Psychiatry Clin Neurosci 260:175-180
23. Pariante CM, Miller AH (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49:391-404
24. Plotsky PM, Owens MH, Nemeroff CB (1998) Psychoneuroendocrinology of depression: hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 21:293-307
25. Rota E, Broda R, Cangemi L, Migliaretti G, Paccotti P, Rosso C, Torre E, Zeppegno P, Portaleone P (2005) Neuroendocrine (HPA axis) and clinical correlates during fluvoxamine and amitriptyline treatment. Psychiatry Res 133:281-284
26. Sargent PA, Quested DJ, Cowen PJ (1998) Clomipramine enhances the cortisol response to 5-HTP: implications for the therapeutic role of 5-HT2 receptors. Psychopharmacology 140:120-122
27. Schüle C (2006) Neuroendocrinological mechanisms of actions of antidepressant drugs. J Neuroendocrinol 19:213-226
28. Tucker P, Beebe KL, Burgin C, Wyatt DB, Parker DE, Masters BK, Nawar O (2004a) Paroxetine treatment of depression with PTSD: effects on autonomic reactivity and cortisol secretion. J Clin Psychopharmacol 24:131-140
29. Tucker P, Ruwe WD, Masters B, Parker DE, Hossain A, Trautman RP, Wyatt DB (2004b) Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biol Psychiatry 56:121-128
30. WHO (2012) http://apps.who.int/classifications/apps/icd/icd10online/ Accessed 25 Jul 2012
31. Yang T-T, Hsiao F-H, Wang K-C, Ng S-M, Ho RTH, Chan CLW, Lai Y-M, Chen Y-T (2009) The effect of psychotherapy added to pharmacotherapy on cortisol responses in outpatients with major depressive disorder. J Nerv Ment Dis 197:401-406